| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/04/2004 | CN1518546A Selective anthranilamide pyridine amides as inhibitors of VEGRF-2 and VEGFR-3 |
| 08/04/2004 | CN1518543A Pyrazole derivatives and their use as protein kinase inhibitors |
| 08/04/2004 | CN1518542A Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes |
| 08/04/2004 | CN1518541A Phenyl derivatives |
| 08/04/2004 | CN1518463A Safety shield system for prefilled syringes |
| 08/04/2004 | CN1518459A Remedies for eosinophilic diseases |
| 08/04/2004 | CN1518453A Anti-stress agents |
| 08/04/2004 | CN1518447A Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents |
| 08/04/2004 | CN1517437A Vaccine for specificity treating tumour or endocellular infection and application |
| 08/04/2004 | CN1517342A Chinese torreya taxadol treatment method used for anticancer and antisanility |
| 08/04/2004 | CN1517121A Antineoplastic medicine and its preparation process |
| 08/04/2004 | CN1517120A Anti-neoplastic medicine and its preparation method |
| 08/04/2004 | CN1517118A 竹提取物及其制备方法和应用 Bamboo extract and its preparation method and application |
| 08/04/2004 | CN1517117A Chinese medicine combined with acupoint treatment for curing hypertension etc. disease |
| 08/04/2004 | CN1517104A Pure natural medicine 'qilong capsule' possessing multifunction for treating many kinds cancer |
| 08/04/2004 | CN1517099A Preparation method of clam meat extract and medicinal composition containing same and its application |
| 08/04/2004 | CN1160463C Human papillomaivirus E6/E7 fusion gene and its efficient expression carrier and fusion protein vaccine |
| 08/04/2004 | CN1160457C Recombinant mistletoe lectin (rML) |
| 08/04/2004 | CN1160357C Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizine-5-yl acetic acid |
| 08/04/2004 | CN1160356C Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them |
| 08/04/2004 | CN1160352C Three-site substituted beta-carboline novel compound having anti-HIV and anti-cancer activity, preparation method and its composition and use |
| 08/04/2004 | CN1160345C Method for high yield extraction of paclitaxel from paclitaxel-containing material |
| 08/04/2004 | CN1160343C Aminothiazole inhibitors of cyclin dependent protein kinasses of cells |
| 08/04/2004 | CN1160338C N-[4-(3-chloro-4-fluoro-phenylamino)-7-(-3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, irreversible inihibotr of tyrosine kinases |
| 08/04/2004 | CN1160309C Alkyloxyamino substitued fluorenones and their use as protein kinase C inhibitors |
| 08/04/2004 | CN1160120C Method for producing anti-cancer medicine from silkworm |
| 08/04/2004 | CN1160099C Anti-cancer capsule and preparation process thereof |
| 08/04/2004 | CN1160084C Active centipede extract for suppressing cancer and its extracting process |
| 08/04/2004 | CN1160069C Palladium-substd. bacteriochlorophll derivatives and use thereof |
| 08/04/2004 | CN1159984C Prophylactic dietary supplement based on milk |
| 08/03/2004 | US6770787 Heavier halogen atom substituted squaraine based dyes, process for the preparation thereof and use thereof as sensitizers for photodynamic, therapeutical and industrial applications |
| 08/03/2004 | US6770778 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters |
| 08/03/2004 | US6770742 Use of inhibitors for the treatment of disorders related to RTK hyperfunction, especially cancer |
| 08/03/2004 | US6770653 Method and dosage form for treating tumors by the administration of tegafur, uracil, folinic acid, paclitaxel and carboplatin |
| 08/03/2004 | US6770652 Multiple acting anti-angiogenic and cytotoxic compounds and methods for using the same |
| 08/03/2004 | US6770651 A2B adenosine receptor antagonists |
| 08/03/2004 | US6770644 Hydroxamic acid derivatives, process for the production thereof and drug containing the same as the active ingredient |
| 08/03/2004 | US6770643 Inhibit protein kinases |
| 08/03/2004 | US6770629 Polymerase inhibitor; anticancer agent |
| 08/03/2004 | US6770627 Piperizine-4-phenyl derivatives as inhibitors of the interaction between mdm2 and p 53 |
| 08/03/2004 | US6770626 Amino acid sequence from certain regions of tissue growth factor-beta super family serine-threonine kinase receptors |
| 08/03/2004 | US6770620 Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disorders |
| 08/03/2004 | US6770619 Lung surfactant compositions with dynamic swelling behavior |
| 08/03/2004 | US6770456 Endogenous retrovirus tumor associated nucleic acids and antigens |
| 08/03/2004 | US6770450 By use of biological agents which either recognize an extracellular domain of prostate specific membrane antigen or bind to and are internalized with prostate specific membrane antigen |
| 08/03/2004 | US6770438 Oncogene, oncoprotein; associated with tumorigenicity; mn genes from cellular component of matu, a quasi viral agent derived from a human mammary tumor |
| 08/03/2004 | US6770304 Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol |
| 08/03/2004 | US6770299 Lipid matrix-drug conjugates particle for controlled release of active ingredient |
| 08/03/2004 | US6770267 Methods of treating periodontal disease |
| 08/03/2004 | CA2233457C Pharmaceutical angiostatic dipeptide compositions and methods of use thereof |
| 08/03/2004 | CA2041093C A pharmacological composition containing polyelectrolyte complexes in microparticulate form and at least one active substance |
| 07/29/2004 | WO2004063711A2 Use of adiponectin to diagnose and treat malignancy |
| 07/29/2004 | WO2004063380A1 Series of recombinant adeno-associated virus useful for inducing rnai pathway and gene therapy |
| 07/29/2004 | WO2004063363A1 Different dendritic cell subsets |
| 07/29/2004 | WO2004063336A2 Uses of deazapurines for the treatment of reperfusion injuries, osteoporosis and/or bone metastasis |
| 07/29/2004 | WO2004063221A1 Metastin derivative and use thereof |
| 07/29/2004 | WO2004063217A1 Dimerized peptide |
| 07/29/2004 | WO2004063211A1 Carbohydrate derivatives of paclitaxel and docetaxel, method for producing same and use thereof |
| 07/29/2004 | WO2004063199A1 Porphyrin derivatives, methods for obtaining same, and use thereof in radioimmunotherapy |
| 07/29/2004 | WO2004063198A1 Diazepinoindole derivatives as kinase inhibitors |
| 07/29/2004 | WO2004063195A1 Pyridopyrimidine kinase inhibitors |
| 07/29/2004 | WO2004063189A1 Ondansetron forms and processes of making the same |
| 07/29/2004 | WO2004063186A1 Thiophene-carboxamide derivatives and their use as inhibitors of the enzime ikk-2 |
| 07/29/2004 | WO2004063169A1 Hydroxamid acid derivatives as histone deacetylase (hdac) inhibitors |
| 07/29/2004 | WO2004063167A1 Blood-brain barrier disruption inhibitors |
| 07/29/2004 | WO2004063146A1 Hydroxamic acid derivatives having anti-inflammatory action |
| 07/29/2004 | WO2004063024A2 Floral packaging material having prints thereon |
| 07/29/2004 | WO2004062691A1 Agent improving proton-driven transporter-mediated absorption in digestive tract and process for producing the same |
| 07/29/2004 | WO2004062686A2 Therapeutic use of modulators of notch |
| 07/29/2004 | WO2004062675A1 Method of modulating il-6 |
| 07/29/2004 | WO2004062671A2 Pde4 inhibitors for the treatment of neoplasms of lymphoid cells |
| 07/29/2004 | WO2004062664A1 Sulfhydantoins as phosphate isosteres for use as phosphatase inhibitors in the treatment of cancer and autoimmune disorders |
| 07/29/2004 | WO2004062654A1 Use of cyclin d1 inhibitors |
| 07/29/2004 | WO2004062609A2 Pyrimidine derivatives as il-8 receptor antagonists |
| 07/29/2004 | WO2004062592A2 2-o sulfatase compositions and related methods |
| 07/29/2004 | WO2004062551A2 RECOMBINANT VHH SINGLE DOMAIN ANTIBODY FROM CAMELIDAE AGAINST VON WILLEBRAND FACTOR (vWF) OR AGAINST COLLAGEN |
| 07/29/2004 | WO2004052349A3 Compositions comprising a combination of diphenyl ura impdh inhibitors and apoptosis-inducing anti-cancer agents |
| 07/29/2004 | WO2004050086A8 Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics |
| 07/29/2004 | WO2004046191A3 Antibodies binding to human magic roundabout (mr), polypeptides and uses thereof for inhibition angiogenesis |
| 07/29/2004 | WO2004045533A3 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 07/29/2004 | WO2004043993A3 Novel ampiphilic fluorocarbon molecular vectors for biomedical and medical use |
| 07/29/2004 | WO2004041297A3 Modified cytokines for use in cancer therapy |
| 07/29/2004 | WO2004037173A3 Method for treating erectile dysfunction and increasing libido in men |
| 07/29/2004 | WO2004035613A3 4-methylhexanoic kahalaide f compound |
| 07/29/2004 | WO2004035590A3 Meso-substituted porphyrins |
| 07/29/2004 | WO2004035536A3 Azo compounds for type i phototherapy |
| 07/29/2004 | WO2004021996A3 Backbone-substituted bifunctional dota ligands, complexes and compositions thereof, and methods of using same |
| 07/29/2004 | WO2004019910A3 Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract |
| 07/29/2004 | WO2004018419B1 Benzimidazole quinolinones and uses thereof |
| 07/29/2004 | WO2004013091A3 4-anilido substituted quinazolines and use thereof as inhibitors of epidermal growth factor receptor kinases |
| 07/29/2004 | WO2004010972A3 Pellicle-resistant gelatin capsule |
| 07/29/2004 | WO2003104181A3 Compounds that abrogate dna-damage-induced cell cycle g2 checkpoint and/or augment the anti-cancer activity of dna-damaging treatments |
| 07/29/2004 | WO2003102148A3 Human prolactin antagonist-angiogenesis inhibitor fusion proteins |
| 07/29/2004 | WO2003094861A3 Bis-benzimidazoles and related compounds as potassium channel modulators |
| 07/29/2004 | WO2003094850A3 Lipid a and other carbohydrate ligand analogs |
| 07/29/2004 | WO2003086317A3 Protein a compositions and methods of use |
| 07/29/2004 | WO2003075741A3 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN αvβ3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE |
| 07/29/2004 | WO2003070881A3 RNA INTERFERENCE MEDIATED INHIBITION OF PROTEIN TYPROSINE PHOSPHATASE-1B (PTP-1B) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 07/29/2004 | WO2003059951A8 Novel anti-igf-ir antibodies and uses thereof |
| 07/29/2004 | WO2003059355A8 Quinazolinone compounds in combined modalities for improved cancer treatment |